Polaris Market Research today announced findings from its latest report, projecting the Europe Equine Healthcare market to grow from USD 1,198.76 million in 2024 to USD 1,959.48 million by 2032, at a CAGR of 6.3%. The report profiles 14 leading companies across five segmentation dimensions and ten country groupings.

Analyst Commentary on Europe Equine Healthcare Market Growth

“Higher disease prevalence, stricter animal welfare expectations, and the growth of equestrian activity are pushing horse owners toward preventive care, which is lifting overall market growth across the region,” said an analyst at Polaris Market Research. “The clearest opportunity lies in digital tools such as telehealth, imaging, and practice management software, where adoption is accelerating among veterinarians.”

Europe Equine Healthcare Market Statistics at a Glance

• 2024 Market Size: USD 1,198.76 million (up from USD 1,128.78 million in 2023)
• 2032 Projected Size: USD 1,959.48 million
• CAGR (2024–2032): 6.3%
• Largest Country (2023): United Kingdom
• Largest Segments (2023): Pharmaceuticals by product; sports and racing by activity
• Product Segment to Watch: Software

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: A high prevalence of equine diseases, the expansion of equestrian sports and recreational riding, and supportive government initiatives are the primary forces behind the market’s expansion, alongside growing demand for vaccines, diagnostics, and digital veterinary tools. Higher disease prevalence prompts a stronger emphasis on preventive care, including vaccinations, parasite control, and biosecurity measures, while rising horse numbers, driven by recreational riding, competitive sport, and breeding, increase demand for veterinary care and health management. Stringent animal welfare rules encourage regular check-ups, and the European Commission’s EUNetHorse project under Horizon Europe promotes knowledge exchange to improve equine healthcare. New entrants, including France-based start-up Coho, which built a stable-monitoring application, are widening choice for owners, and Dechra, one of Europe’s top brands in horse medicine, continues to develop drugs and vaccines. A shortage of trained equine veterinarians, particularly in rural areas, remains a restraint.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/europe-equine-healthcare-market

Major Companies Covered: Zoetis Services LLC, Boehringer Ingelheim International GmbH, Dechra, Ceva Santé Animale, Merck & Co., Inc., Heska Corporation, IDEXX Laboratories, Inc., Elanco, and Covetrus Inc. Leading players are investing in research and development, product launches, collaborations, and acquisitions to strengthen their regional presence. Zoetis and Dechra are among the companies expanding portfolios through diagnostics and vaccine launches.

Segments Covered: By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software), By Indication (Musculoskeletal Disorders, Parasitic Infections, Equine Influenza, West Nile Virus, Tetanus), By Activity (Sports/Racing, Recreation), By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities), By Country.

Segment Highlights: Pharmaceuticals led in 2023 on demand for treatments for respiratory infections and musculoskeletal issues, while software is expected to grow at a robust pace as practices adopt electronic health records, telemedicine, and analytics tools to improve diagnostic accuracy and treatment planning. Sports and racing held the largest activity share because high-value racehorses and competition horses require rigorous care to sustain performance and prevent injuries, while recreation is projected to register a significant CAGR.

Recent Developments in the Europe Equine Healthcare Market

• March 2023: Zoetis expanded its Vetscan Imagyst diagnostics platform with two new applications, AI dermatology and AI equine fecal egg count analysis.
• August 2022: Dechra Pharmaceuticals launched Strangvac, a protein-based vaccine protecting horses and ponies against strangles.
• August 2021: Dechra launched Equibactin, a new antibiotic oral powder for treating bacterial infection in horses.

Regional Snapshot: UK Leads, Germany Set for Rapid Growth

The UK held the largest share in 2023, supported by growing recreational riding, a large equestrian community, strong infrastructure for competitive and recreational equestrian activity, rising interest in horse welfare and preventive care, and a higher incidence of equine influenza, West Nile virus, and tetanus. Germany is projected to grow at a rapid pace through 2032, backed by a well-established equestrian industry, a strong tradition in equine sports and racing, advanced veterinary research institutions, and a network of specialized clinics. The report also covers France, Italy, Spain, Switzerland, Sweden, the Netherlands, and Russia.

Why It Matters for Stakeholders Tracking the Europe Equine Healthcare Market Forecast

For stakeholders researching the Europe equine healthcare market forecast, the underlying report benchmarks Europe equine healthcare market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2032. Country-level projections help pinpoint where demand is building, while product, indication, activity, and distribution channel analysis shows how veterinary hospitals and clinics, e-commerce, and equestrian facilities are positioned as channels to market. Revenue is presented in USD million from 2019 to 2032. The indication analysis spans musculoskeletal disorders, parasitic infections, equine herpes virus, equine viral arteritis, equine influenza, West Nile virus, and tetanus.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

acai-berry-market

protein-ice-cream-market

calcium-carbonate-market

solar-panels-market

nitrous-oxide-market

peptide-therapeutics-market

forage-market

biogas-market

wood-pellet-market